M4K Pharma Steering Committee

The M4K Steering Committee serves as the central coordination and decision-making body for the organization’s DIPG drug development program. The Steering Committee is composed of representatives of key program contributors and funders, alongside independent experts from relevant disciplines or backgrounds.

The Committee meets quarterly and has the following responsibilities:

• Review and approval of preclinical and clinical development plans and priorities.

• Evaluation of project progress and consideration of adjustments to development strategies.

• Approval of the general allocation of existing financial resources to support project goals.

• Evaluation of the suitability of potential new collaborations, partners and funders.